Viewing entries posted in 2014

Sequana Medical’s new alfapump® with DirectLink Technology improves the care of patients with challenging refractory ascites

1 December 2014

Technological advances in Sequana Medical’s alfapump system will allow patients and their doctors to better manage the distressing symptoms of refractory ascites. With enhanced communications enabled by the new DirectLink Technology, clinicians will now be able to monitor the alfapump remotely.

Read more

Financial Times reports that Sequana Medical’s raises $26 million in Series C financing round

28 April 2014

The Financial Times, one of the world’s leading business news organisations, reported today that Sequana Medical has raised $26 million in a Series C financing round.

Read more

alfapump® at the International Liver Congress 2014 in London

9 April 2014

Sequana Medical is delighted to be attending this year’s International Liver Congress in London.

Read more

HUG Geneva adds the alfapump® system to its range of treatments for refractory ascites

24 February 2014

Sequana Medical is delighted to report that HUG, the university hospital of Geneva, is now offering the alfapump system as a treatment option for patients suffering from refractory ascites.

Read more

Britain’s ‘Sun’ newspaper reports that the alfapump® system gives hope to liver patients

7 January 2014

The alfapump system featured once again in the British press, this time in the ‘Sun’ newspaper.

Read more